
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 99.890 | 99.900 | 0.010 |
Other | 0.330 | 0.360 | 0.030 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.372 | 23.952 |
Price to Book | 5.861 | 4.790 |
Price to Sales | 5.216 | 3.625 |
Price to Cash Flow | 19.650 | 16.435 |
Dividend Yield | 0.655 | 1.233 |
5 Years Earnings Growth | 14.118 | 12.200 |
Name | Net % | Category Average |
---|---|---|
Technology | 50.010 | 28.530 |
Industrials | 13.640 | 12.068 |
Healthcare | 13.020 | 14.638 |
Consumer Cyclical | 8.950 | 12.584 |
Financial Services | 7.300 | 14.460 |
Communication Services | 3.200 | 9.021 |
Real Estate | 2.380 | 1.752 |
Utilities | 1.500 | 2.313 |
Number of long holdings: 384
Number of short holdings: 285
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 6.02 | 94.31 | -7.36% | |
Amazon.com | US0231351067 | 4.59 | 171.00 | -4.15% | |
Microsoft | US5949181045 | 3.72 | 359.84 | -3.56% | |
Alphabet A | US02079K3059 | 3.19 | 145.60 | -3.40% | |
Mastercard | US57636Q1040 | 3.14 | 489.77 | -7.69% | |
Nutanix | US67059N1081 | 3.09 | 58.50 | -9.69% | |
Hitachi | JP3788600009 | 2.69 | 3,054.0 | -5.83% | |
Oracle | US68389X1054 | 2.66 | 128.27 | -6.53% | |
Boston Scientific | US1011371077 | 2.65 | 89.70 | -8.93% | |
Schneider Electric | FR0000121972 | 2.43 | 189.50 | -6.65% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1530899142 | 2.93B | -1.00 | 5.53 | - | ||
LU1903290036 | 2.93B | -1.19 | 3.30 | - | ||
LU1530900684 | 2.93B | -0.85 | 6.58 | - | ||
LU1902443420 | 1.68B | 3.07 | 9.75 | - | ||
LU1902444402 | 1.68B | 2.89 | 8.68 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review